Overall agreement 40%: A+ 15%, A 25%, A 20%, D 20%, D 20%, D+ 0%
GLP-1 therapy affects more than weight
PALO ALTO, Calif., September 28, 2023 (BUSINESS WIRE)-- Digbi Health, the leader in precision biology-based telehealth care for three of the top four healthcare costs - Obesity, T2D, and Digestive Health - announced today the launch of its latest innovation in obesity care, Digbi GLP-Fit, a scientifically-backed approach to identify the best treatment path for an individual to prevent and treat obesity
After an investigation, the board found that more than a thousand of Empowers vitamin C injectables shipped into the state had been adulterated or made with lower quality ingredients because they contained food additive ingredients from an unregistered manufacturer, records say